Schwar Capital Research

Schwar Capital Research

KFS Q1 2026: The J-Curve Has Turned.

Adjusted EBITDA up 78%, KSX at record profitability, every business firing at once. And there is a quiet re-rating catalyst nobody is pricing in.

Schwar Capital Research's avatar
Schwar Capital Research
May 15, 2026
∙ Paid

To read our full disclaimer, click here.

Kingsway just reported Q1 2026 earnings. The headline numbers:

  • Consolidated revenue of $39.0 million, up 37.4% year-on-year

  • KSX revenue of $21.1 million, up 80.7%

  • Extended Warranty revenue of $17.9 million, up 7.2%; Extended Warranty cash sales up 11.8%

  • Consolidated adjusted EBITDA of $2.4 million, up from $1.4 million

  • KSX adjusted EBITDA of $3.5 million, up 82% - a record quarter for the segment

  • Extended Warranty adjusted EBITDA of $0.4 million, down from $0.9 million

  • Consolidated net loss of $2.2 million, narrowed from a $3.1 million loss

  • Portfolio LTM EBITDA of $22.0 to $23.0 million

  • Total net debt of $63.9 million, up from $62.4 million at year-end

When I wrote the Q4 update in March, the title was “The J-Curve Is Turning.”

The argument was that the margin compression which ran through 2025 was a predictable feature of the acquisition model, not a structural problem, and that there was now real, granular evidence the recovery had begun.

This quarter confirms it.

The company still printed a GAAP net loss. Net debt ticked up rather than down. Extended Warranty adjusted EBITDA was lower year-on-year. None of those are nothing. But every one of them is explainable, and the underlying trajectory across the portfolio is no longer ambiguous.

The following is my personal take and what I am doing with my position.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Schwar Capital · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture